Analytical instrumentation provider for the R&D and manufacturing of protein drugs
Joined March 2017
- Tweets 170
- Following 1
- Followers 38
- Likes 2
139 Photos and videos
2 Aug 2022
New Application Note now available! Protein Dilution and Subsequent Concentration Provide a Well-Matched Sample/Buffer Pair for High-Resolution MMS
Access now! ow.ly/q0uE50K9OvO
1
3
9 Jun 2022
There is still time to register for today's webinar! Learn how Amgen uses #MMS to increase productivity and de-risk product failure in their biotherapeutic #formulation process by more confidently detecting changes in #proteinstructure.
Register now! ow.ly/J1AO50JtAvS
RedShiftBio retweeted
9 May 2022
@redshiftbio releases biomolecule characterization technology buff.ly/3FrrJDa
1
1
RedShiftBio retweeted
23 Feb 2022
@OGConferences would like to welcome @redshiftbio to Formulation UK In-Person event in London on the 5th - 6th May.
Take a look at the website and see how you can meet them on-site.
hubs.la/Q014zXPs0
#FormulationSeries22 #DrugDelivery #Formulation
1
22 Feb 2022
New Application Note now available on #MMS as a non-destructive structural characterization technique. #proteinanalysis
ow.ly/B9jz50I11xP
RedShiftBio retweeted
11 Jan 2022
@OGConferences next confirmed sponsor for Biologics UK In-Person 2022 is @redshiftbio
Visit the website to find out how you can meet the team on site in March.
hubs.la/Q011Mtcv0
#BiologicsSeries2022 #Peptides #Proteins
1
1
27 Jan 2022
We work with mAbs and have proven that even in the presence of complex formulation buffers, secondary structural characterization using MMS is faster and more sensitive compared to traditional technology. Learn more. ow.ly/Q7sG50HEUo6
18 Jan 2022
#PEPTALK2022 Join Us Tuesday 3:10 PM PST to learn about how Microfluidic Modulation Spectroscopy enables researchers to characterize protein secondary structure and aggregation in real-time, yielding insights that accelerate biotherapeutics development.ow.ly/PKmH50HuGF5
17 Jan 2022
Join us at #PEPTALK2022 as we demonstrate how Microfluidic Modulation Spectroscopy accelerates biotherapeutics development. Visit booth #208 today!
#PTK22 #biotherapeutics #secondarystructure
10 Jan 2022
We've revolutionized #secondarystructure analysis. Microfluidic Modulation Spectroscopy produces consistent data in the analysis of secondary protein structure beyond that supplied by current techniques. Learn more ow.ly/SzIW50HoBo3
6 Jan 2022
Secondary Structure: It's More Than Just an Afterthought. The structure of a protein plays a fundamental role in the performance of biotherapeutics.
ow.ly/QNG550HoEmf
9 Dec 2021
#Proteinstructure can be monitored at various steps of the manufacturing process to alert scientists about undesired changes that can affect function. Secondary structure analysis, using MMS, is central to this verification process. ow.ly/8f4Z50H30bg
3 Dec 2021
[On-demand] Watch our presentation from #PEGSEurope and discover how the increased sensitivity and reproducibility of MMS was used and compared to standard techniques for determination of #secondarystructure to rank potential formulations.
ow.ly/eQI050H36Uq
1
1
16 Nov 2021
We are excited to share the news about our new partnership with
Read our full release here. ow.ly/P5Wq50GPcrU
1
2
9 Nov 2021
There's still time to submit your StructIR Lab Grant! We're accepting applications through November 15th, with two grant winners being selected to work with our team of MMS experts.
redshiftbio.com/resources/st…
3 Nov 2021
Learn how #MMS can examine and rank potential formulations with increased measurement sensitivity & reproducibility over standard techniques for #biomolecule #secondarystructure determination! Our presentation featuring Dr. Rob Forbes is at 4:20pm tomorrow #PEGSEurope!
1 Nov 2021
We hope to see you at #PEGSEurope this week! Stop by our booth and learn how the AQS3pro is improving product development workflows through innovation in IR analysis.
Don’t miss our presentation on November 4th at 4:20pm!
ow.ly/7pRY50GyM2I
1
1
18 Oct 2021
Excited to announce the close of our Series E funding! Read our full release below.
ow.ly/nHXo50Gtv9R
1